Bio Place

Latest Medical, Biological, and Genomic News!


Ozempic and Wegovy may reduce risk of heart disease as well

"After a year of taking semaglutide, marketed as Wegovy, patients’ risk of suffering from conditions like a heart attack or a stroke over the next ten years dropped to 6.3% from 7.6% when measured by a commonly used calculator."
2023-05-21 06:31:32